BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  HealthLynked Corp. Reports Second Quarter 2018 Results, including 10% Revenue Growth in the Second Quarter of 2018

  10% increase in revenue in Q2 2018 compared to Q2 2017

  August 15, 2018

   · 

  4 min read
• Business

  Targovax ASA: Invitation to Second Quarter and First Half Year 2018 Results Presentation Thursday 23 August

  Targovax ASA will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation by Targovax’s management to investors, analysts and the press will take place in Oslo at 10:00 CET.

  August 15, 2018

   · 

  1 min read
• Deals

  Generational Equity Advises Protouch Staffing in Sale to W3Global

  The acquisition closed June 28, 2018.

  August 15, 2018

   · 

  2 min read
• Business

  Leadiant Biosciences to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy

  Multi-Center Collaborative Clinical Trial Planned to Test Efficacy of Oral-N-acetyl-D-Mannosamine

  August 15, 2018

   · 

  5 min read
• Business

  VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development

  VBI Vaccines Inc.

  August 15, 2018

   · 

  4 min read
• Business

  BioCorRx Provides Business Update for the Second Quarter of 2018

  BioCorRx Inc. today provided a business update for the second quarter ended June 30, 2018.

  August 15, 2018

   · 

  3 min read
• Pharm Country

  HSS and Ivy Rehab to Create Physical Therapy Centers of Excellence Nationwide

  First Center to Open in Englewood, NJ

  August 15, 2018

   · 

  4 min read
• Policy

  MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

  Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research

  August 15, 2018

   · 

  5 min read
• Biotech Beach

  Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations

  Program supports breast cancer and reconstruction research and education

  August 15, 2018

   · 

  3 min read
• Policy

  Loncar China BioPharma ETF (CHNA) Launches on Nasdaq

  CHNA offers diversified exposure to leading companies in China’s burgeoning BioPharma industry

  August 15, 2018

   · 

  7 min read